You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國際醫學(000516.SZ)確定新增回購股份亦全部用於實施股權激勵計劃
格隆匯 11-14 20:11

格隆匯11月14日丨國際醫學(000516.SZ)公佈,公司於2019年11月14日召開第十一屆董事會第十一次會議,會議審議通過了《關於確定新增回購股份用途的議案》。

公司分別於2019年10月28日召開第十一屆董事會第十次會議,2019年11月14日召開2019年第二次臨時股東大會,審議通過了《關於調整回購股份方案的議案》,將公司正在實施的回購股份方案中回購資金總額由“不低於人民幣3.75億元(含),不超過人民幣7.5億元(含)”調整為“不低於人民幣2.3億元(含),不超過人民幣4.6億元(含)”。

基於對公司未來發展的信心,為進一步健全公司長效激勵機制,有效地將股東利益、公司利益和核心員工利益結合在一起,充分調動公司高級管理人員、核心及骨幹人員的積極性,促進公司戰略目標的實現及長期持續穩定發展,經第十一屆董事會第十次會議審議通過,已決定將回購的股份4281.7629萬股用於實施股權激勵計劃。董事會決定除已回購的股份4281.7629萬股外,在回購實施期限內新增的回購股份亦全部用於實施股權激勵計劃。

如公司實施股權激勵計劃後,回購股份未授出或未全部授出,則未授出股份依法履行審議程序後予以註銷。回購股份應當在公司披露回購結果公告後三年內轉讓或者註銷。根據公司2018年第四次臨時股東大會授權,確定本次新增回購股份用途事項無需提交公司股東大會審議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account